NeuroServo

NeuroServo

next-gen EEG, Cerebral Function Monitoring, pathology detection algorithms

Founded 2015 Canada

Montreal, Canada 6 employees Seed Total: $3.34M Health Care, Medical Devices

NeuroServo, a Canadian startup founded in 2015, specializes in next-generation EEG and Cerebral Function Monitoring with advanced pathology detection algorithms. The company has developed a miniaturized, non-intrusive, portable, instant-use, and motion-resistant brain wave capture device (EEG). This device captures brain waves and analyzes them in real-time using NeuroServo algorithms, enabling early detection of cerebral pathologies like delirium. The company recently secured a significant $2.20M in a Seed Round investment on 20 June 2023. This investment was led by Desjardins Capital, Investissement Québec, and the Center of Aging and Brain Health Innovation. This indicates a strong investor interest in NeuroServo's innovative technology and its potential impact in the healthcare industry. In an industry where early detection and monitoring of cerebral functions are critical, NeuroServo's technology presents promising solutions. The company's focus on advancing EEG capabilities and pathology detection can have a profound impact on the diagnosis and treatment of neurological conditions. With the substantial investment received, NeuroServo is well-positioned to further develop and commercialize its cutting-edge solutions, potentially reshaping the landscape of cerebral health monitoring.

Funding Stage	Amount	Investors	Lead Investors	Date
Seed Round	$2.30M	3	Desjardins Capital, Investissement Québec +1	20 Jun 2023
Non Equity Assistance	Undisclosed	5	National Bank of Canada, Centech Mtl +3	20 Apr 2023
Seed Round	Undisclosed	1	Private Investors	01 Aug 2022
Pre Seed Round	$1.01M	1	Desjardins Venture Capital	01 Feb 2020
Non Equity Assistance	$30.00K	1	Centech Mtl	01 Jan 2019

Funding Stage

Amount

Investors

Lead Investors

Date

Seed Round

$2.30M

Desjardins Capital, Investissement Québec +1

20 Jun 2023

Non Equity Assistance

Undisclosed

National Bank of Canada, Centech Mtl +3

20 Apr 2023

Seed Round

Undisclosed

Private Investors

01 Aug 2022

Pre Seed Round

$1.01M

Desjardins Venture Capital

01 Feb 2020

Non Equity Assistance

$30.00K

Centech Mtl

01 Jan 2019

FAQ About NeuroServo

next-gen EEG, Cerebral Function Monitoring, pathology detection algorithms

NeuroServo was founded in 2015.

NeuroServo is headquartered in Montreal, Canada.

NeuroServo operates in Health Care and Medical Devices. Its work centres on EEG, brain wave capture device, cerebral function monitoring and pathology detection algorithms.

NeuroServo has approximately 6 employees.

NeuroServo has completed 5 funding rounds, raising a total of $3.34M. The latest funding stage is Seed.

Top alternatives and competitors to NeuroServo include Cerenion Oy, CenSyn, Inc., NeuroVigil, Inc., FIZE Medical , CROSS SYNC, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

NeuroServo and Cerenion Oy are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About NeuroServo

Funding Rounds & Investors (5)

NeuroServo Alternatives & Competitors

FAQ About NeuroServo